Data / Form D filings / Notch Therapeutics, Inc.
Notch Therapeutics, Inc.: Form D filing
Notch Therapeutics, Inc., a company in Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2024. The latest, on June 17, 2024, reports $15.5 million sold of a $15.5 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 300-2233 Columbia Street, Vancouver, British Columbia, Canada, V5Y 0
- Phone
- (778) 654-8588
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1847926
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | New notice | $15,499,990 | $15,499,990 | 16 | May 17, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Caroline R. Stout | Director | |
| Bernard R. Lam | Executive Officer | |
| Kamran R. Alam | Executive Officer | |
| Ulrik R. Nielsen | Director | |
| Heather R. Lee | Director | |
| Emily R. Titus | Executive Officer | |
| Janet R. Rossant | Director | |
| Chris R. Bond | Executive Officer | |
| Stephen R. Biggar | Director | |
| David Main | Executive Officer, Director |
Every Form D from the week of Jun 17, 2024 · All recent Other filings
Read from SEC EDGAR. Amount sold is what Notch Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.